Skip to main content
NeopharmCO.,LTD. logo

NeopharmCO.,LTD. — Investor Relations & Filings

Ticker · 092730 ISIN · KR7092730001 KO Manufacturing
Open in API
Filings indexed 205 across all filing types
Latest filing 2021-02-08 Earnings Release
Country KR South Korea
Listing KO 092730

About NeopharmCO.,LTD.

https://neopharm.co.kr

Neopharm is a science-based company specializing in the development, manufacturing, and sale of dermatological skincare and cosmetic products. A pioneer in skin barrier research, the company focuses on restoring skin homeostasis. Its core innovation is the proprietary Multi-Lamellar Emulsion (MLE) technology, which mimics the natural lipid structure of the skin to repair and strengthen its protective functions. The company's primary product lines, including the flagship brand Atopalm, are specifically formulated for sensitive, dry, and compromised skin. These non-steroid solutions are grounded in dermatological science to address various skin concerns.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Neopharm, detailing quarterly financial performance (revenue, operating profit, net income) for the period ending 2020-12-31. It provides key financial highlights and is explicitly labeled as a provisional report (잠정치) subject to audit. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodic financial results. Q4 2020
2021-02-08 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from NeoPharm regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend record date, and the approval process via the general meeting of shareholders. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2021-02-08 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal regulatory notice of a corporate action. Given the nature of the announcement, it falls under the general regulatory filing category.
2020-12-11 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'NeoPharm' covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial information, business operations, management discussions, and shareholding data. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. 9M 2020
2020-11-13 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Neopharm, detailing quarterly financial performance (revenue, operating profit, net income) for the period ending 2020-09-30. It provides key financial highlights and is clearly an initial announcement of results rather than a full annual or interim report. Under the provided definitions, this fits the 'Earnings Release' (ER) category. Q3 2020
2020-11-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity acquires a significant stake (typically 5% or more) in a listed company. This document details the shareholding status, changes in ownership, and the purpose of the holding by Templeton Asset Management, Ltd. in Neopharm Co., Ltd. This falls under the category of 'Major Shareholding Notification'.
2020-10-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.